Scientists build first cell-type-specific Alzheimer's protein atlas

Alzheimer's disease can affect almost the entire brain, but how different cell types are specifically affected is not fully understood. To address this gap, St. Jude Children's Research Hospital scientists developed a cell type-specific protein atlas using brains from mouse models of Alzheimer's disease. By combining and comparing multiple types of data, they identified over 3,000 proteins with altered levels across a range of cell types, 78% of which had not been captured before.

A focused look at microglia, which express many Alzheimer's disease risk genes, revealed that almost all the changes to this cell type were previously undetected. The approach also uncovered a potential intercellular communication network, where proteins made in one cell type are secreted and function in another cell type. The findings, published today in Neuron, provide much-needed cell type-specific context to the pathology of Alzheimer's disease.

Single-cell RNA sequencing has revolutionized Alzheimer's disease research, but it provides only a partial view of cellular activity. Proteomic profiling fills many gaps, but has largely been limited to bulk analysis, resulting in lost context. Now, by combining next-generation mass spectrometry methods with single-cell RNA sequencing and spatial omics, co-corresponding authors Junmin Peng, PhD, Departments of Structural Biology and Developmental Neurobiology and Jiyang Yu, PhD, Department of Computational Biology interim chair, obtained the needed cell type-specific information.

This is the first cell-type-resolved proteomic analysis we are aware of in the Alzheimer's disease field. When we compared our data to bulk datasets, we found that a large portion of the protein level changes we detected are new. We also identified many potential disease drivers that can be targeted in future follow-up studies."

Junmin Peng, Department of Computational Biology, St. Jude Children's Research Hospital 

Integrated approach identifies RNA-protein level mismatch

Using two Alzheimer's disease mouse models, the team profiled over 13,000 proteins across multiple ages and cell types. This profiling allowed direct comparison with single-cell RNA sequencing data, identifying thousands of cell type-specific changes in proteins, pathways and intercellular signaling networks.

"Because our lab specializes in deep proteomics, we were able to generate exceptionally robust datasets. That depth allowed meaningful comparisons with RNA data," said co-first author Xue Zhang, PhD, a postdoctoral researcher in Peng's lab. "Without sufficient coverage, such integration and analysis would not be possible."

"By obtaining high-resolution cell-type proteomics, we now have an additional layer of information, especially with matched samples analyzed using multiple methods and at different levels of resolution," said Yu. "These technologies enable us to understand disease mechanisms more comprehensively and identify specific cellular interactions, for example between microglia and astrocytes."

Of note, RNA-protein level comparisons revealed that proteins found in one cell type were expressed by, and secreted from, another cell type. This was the case for the protein pleiotrophin, for which high RNA levels were noted in astrocytes, but high protein levels were found in microglia.

"Because those proteins are secreted, this suggested an interesting form of intercellular communication," explained Peng. "Gene regulation may occur in astrocytes, but after translation and secretion, the proteins function in microglia."

The atlas and accompanying datasets, available at https://penglab.shinyapps.io/pannda, provide a valuable resource that will allow researchers to make the leap into single-cell analysis in Alzheimer's disease samples. "True integration has to start with experimental design, not after the data are generated," said co-first author Jiyuan Yang, PhD, a senior computational research scientist in Yu's lab. "It also requires a clear understanding of how different types of data can complement and inform each other. We hope our study provides a useful blueprint for future multi-omics research."

Source:
Journal reference:

Zhang, X., et al. (2026). A cell-type-resolved proteomic atlas reveals intra- and intercellular signaling in Alzheimer’s disease. Neuron. DOI:10.1016/j.neuron.2026.10.019. https://www.cell.com/neuron/fulltext/S0896-6273(26)00815-9.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Single-cell spatial atlas profiles 850,000 cells across breast cancer progression